Two Zio monitors.
All the data you need.

With Zio XT and Zio AT, you’ll have access to two powerful monitors that cover the risk spectrum — and deliver high-quality, accurate data.
Zio XT
Long-Term Continuous Monitor
Female patient wearing Zio XT long-term continuous monitor on chest
Zio XT
Long-Term Continuous Monitor
Zio AT
Mobile Cardiac Telemetry Monitor
Male patient wearing Zio AT mobile cardiac telemetry monitor (MCT) on chest with communication signal via gateway
Zio AT
Mobile Cardiac Telemetry Monitor

The monitor
patients prefer.1

Zio XT and Zio AT were designed with the patient in mind, so they can go about their lives with minimal disruption. No battery charges or replacements, or electrode repositioning are required. As a result, real-world data shows an impressive 98% patient compliance.2

0 patient
manipulations2

98% patient
compliance2

88% of patients
found Zio
easy to use2

83% of patients
would wear
Zio again2

Patients can:
Bicycle icon to show that exercise is possible while wearing a Zio patch
Exercise†
Shower icon to show that showering is possible while wearing a Zio patch
Shower†
Bed icon to show that sleeping is possible while wearing a Zio patch
Sleep

Over 50% of arrhythmias are missed by Holter monitors.6

holter-99
Detected by Zio XT
in 14 days6
47% Detected by Holter in 2 days
Detected by Holter
in 2 days6
See Mary Sue’s experience with Zio.

Cover the risk spectrum
with two monitors.

Zio XT patch long-term continuous monitor

Zio XT
for low-risk patients

  • MONITOR TYPE
    Long-term continuous monitor
    (up to 14 days)
  • ALERTS DURING WEAR PERIOD
    None
  • DAILY REPORTS
    None
  • FINAL REPORT
    Comprehensive final XT patient report at end of prescribed wear period
Zio AT patch mobile cardiac telemetry monitor (MCT) with communication signal via gateway

Zio AT
for high-risk patients

  • MONITOR TYPE
    Mobile cardiac telemetry monitor
    (up to 14 days)
  • ALERTS DURING WEAR PERIOD
    Included
  • DAILY REPORTS
    Yes
  • FINAL REPORT
    Comprehensive final AT patient report at end of prescribed wear period
Zio XT
Zio AT
Zio XT
Zio AT
Long-term continuous monitor
3x
3-times the
diagnostic yield.2, 3
75%
Zio XT
3X
24%
Holter Monitors
23%
Event Monitors
Zio XT is as accurate as the gold standard at detecting AF burden.4
Zio XT vs. implanted pacemaker
R2 = 0.9999 / MSE = 0.2371
% AF Burden (Pacemaker)
Zio XT long-term continuous monitor is on par with gold standard, implanted pacemaker, AF burden
% AF Burden (Zio XT)
Mobile cardiac telemetry monitor
Patients are 98% compliant with Zio because the wear experience is easy, and no manipulations are required.1, 5
Zio AT patch mobile cardiac telemetry monitor (MCT) on patient icon
Other MCT/event monitor on patient icon
Patient
manipulations
Zio AT
Other MCTs & Event Monitors
Electrode/patch replacements
0
3-5+
Sensor charges/battery replacements
0
3-17+
Gateway charges
0
17+
Total required patient manipulations
0
23-29
Zio AT gives you a higher diagnostic yield in less time.2, 3
Up to 14 days of continuous, uninterrupted monitoring helps ensure you get the answers you need in a single test.
83%
Zio AT
(up to 14 days)
61%
Other MCTs
(up to 30 days)
23%
Event Monitors
(up to 30 days)

One application process.
Zio for all of your patients.

Zio XT and Zio AT are single-use monitors, and have been designed for simple application — either in clinic, or by patients in their own homes. When telehealth is desired, Zio will send a monitor directly to your patient’s home and provide patient-friendly instructions to ensure application is as easy as possible.

Clinic icon to show that Zio patches can be applied in clinic setting
Monitors applied in clinic
Home icon to show that Zio patches can be applied by patients at home via telehealth
Monitors applied at home
Dr. Dan Bensimohn, Cone Health, Heart Failure Cardiologist

“People aren’t taking these devices off. They’re leaving them on, and we’re getting the data we need.”

Dr. Dan Bensimhon
Cone Health
Heart Failure Cardiologist
Medical Director, Advanced Heart Failure & Mechanical
Circulatory Support Program

Let’s talk.

We’d love to know how we can help you and your patients.
  1. Avoid excessive sweating. Do not shower for the initial 24 hours.
  2. Zio XT and Zio AT are contraindicated for critical care patients.
  1. Barret, P. et al., Comparison of 24 hour Holter monitoring versus 14 day novel adhesive patch electrocardiographic monitoring. American Journal of Medicine, 2014.
  2. Data on file. iRhythm Technologies, 2020.
  3. Tsang, J.P. et al. Benefits of monitoring patients with mobile cardiac telemetry (MCT) compared with the Event or Holter monitors. Medical Devices: Evidence and Research, 2014.
  1. Eysenck, W., et al. A randomized trial evaluating the accuracy of AF detection by four external ambulatory ECG monitors compared to permanent pacemaker AF detection. Journal of Interventional Cardiac Electrophysiology, 2019.
  2. Traditional Wired MCT: CardioNet MCOTos Patient Education Guide, MCT 3 Lead Patient Guide; Competitor A Patch: MCOT Patch Patient Education Guide; Competitor B Patch: BodyGuardian Heart
  3. Turakhia, M., et al., Diagnostic Utility of a Novel Leadless Arrhythmia Monitoring Device, American Journal of Cardiology, 2013.